These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 19918166

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of beta blockers, angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, and statins on mortality in patients with implantable cardioverter-defibrillators.
    Lai HM, Aronow WS, Kruger A, Desai H, Amin H, Frishman WH, Cohen M, Sorbera C.
    Am J Cardiol; 2008 Jul 01; 102(1):77-8. PubMed ID: 18572039
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Congestive heart failure and arrhythmia].
    Kasanuki H.
    Nihon Rinsho; 1993 May 01; 51(5):1354-61. PubMed ID: 8101240
    [Abstract] [Full Text] [Related]

  • 11. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators.
    Bardy GH, Yee R, Jung W.
    J Am Coll Cardiol; 1996 Aug 01; 28(2):400-10. PubMed ID: 8800117
    [Abstract] [Full Text] [Related]

  • 12. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
    Wilkoff BL, Cook JR, Epstein AE, Greene HL, Hallstrom AP, Hsia H, Kutalek SP, Sharma A, Dual Chamber and VVI Implantable Defibrillator Trial Investigators.
    JAMA; 2002 Dec 25; 288(24):3115-23. PubMed ID: 12495391
    [Abstract] [Full Text] [Related]

  • 13. Left ventricular ejection fraction and absence of ACE inhibitor/angiotensin II receptor blocker predicts appropriate defibrillator therapy in the primary prevention population.
    Obeyesekere MN, Chan W, Stub D, Prabhu S, Teo EP, Toogood G, Mariani J, Broughton A, Kistler PM.
    Pacing Clin Electrophysiol; 2010 Jun 01; 33(6):696-704. PubMed ID: 20059719
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone].
    Della Bella P.
    Ital Heart J Suppl; 2000 Aug 01; 1(8):1070-1. PubMed ID: 10993020
    [No Abstract] [Full Text] [Related]

  • 20. Proarrhythmias and antiarrhythmias: two sides of the same coin.
    Kowey PR, Yan GX.
    Heart Rhythm; 2005 Sep 01; 2(9):957-9. PubMed ID: 16171750
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.